{
    "organizations": [],
    "uuid": "7e9e48bb4718c2139eb151cb4d97b3aacbf5f684",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-arvinas-announces-research-collabo/brief-arvinas-announces-research-collaboration-and-license-agreement-with-pfizer-inc-idUSFWN1OY0NY",
    "ord_in_thread": 0,
    "title": "BRIEF-Arvinas announces research collaboration and license agreement with Pfizer Inc",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 5:13 AM / Updated an hour ago BRIEF-Arvinas announces research collaboration and license agreement with Pfizer Inc Reuters Staff 1 Min Read \nJan 4 (Reuters) - Arvinas LLC: \n* ARVINAS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC. FOR THE DISCOVERY AND DEVELOPMENT OF PROTEIN DEGRADATION DRUG CANDIDATES \n* ANNOUNCED A RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC​ \n* ARVINAS SAYS MAY RECEIVE UP TO $830 MILLION IN UPFRONT AND POTENTIAL DEVELOPMENT AND COMMERCIALIZATION MILESTONE PAYMENTS UPON ACHIEVEMENT OF SPECIFIED MILESTONES​ \n* ‍CO MAY BE ENTITLED TO RECEIVE TIERED ROYALTIES BASED ON GLOBAL PRODUCT SALES ON ANY PRODUCTS THAT MAY RESULT FROM COLLABORATION​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T13:13:00.000+02:00",
    "crawled": "2018-01-04T08:02:06.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "updated",
        "hour",
        "ago",
        "announces",
        "research",
        "collaboration",
        "license",
        "agreement",
        "pfizer",
        "inc",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "arvinas",
        "llc",
        "arvinas",
        "announces",
        "research",
        "collaboration",
        "license",
        "agreement",
        "pfizer",
        "discovery",
        "development",
        "protein",
        "degradation",
        "drug",
        "candidate",
        "announced",
        "research",
        "collaboration",
        "license",
        "agreement",
        "pfizer",
        "arvinas",
        "say",
        "may",
        "receive",
        "million",
        "upfront",
        "potential",
        "development",
        "commercialization",
        "milestone",
        "payment",
        "upon",
        "achievement",
        "specified",
        "may",
        "entitled",
        "receive",
        "tiered",
        "royalty",
        "based",
        "global",
        "product",
        "sale",
        "product",
        "may",
        "result",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}